Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124966292 | 12496629 | 2 | F | 2016 | 20160704 | 20160624 | 20160713 | EXP | GB-009507513-1604GBR010259 | GB-FRESENIUS KABI-FK201603888 | FRESENIUS KABI | 42.00 | YR | F | Y | 0.00000 | 20160713 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124966292 | 12496629 | 1 | PS | ONDANSETRON (MANUFACTURER UNKNOWN) | ONDANSETRON | 1 | Unknown | U | 76972 | UNKNOWN | |||||||||
| 124966292 | 12496629 | 2 | SS | DOCETAXEL (Manufacturer unknown) | DOCETAXEL | 1 | Unknown | U | 0 | UNKNOWN | |||||||||
| 124966292 | 12496629 | 3 | SS | APREPITANT. | APREPITANT | 1 | Oral | 0 | 80 | MG | QD | ||||||||
| 124966292 | 12496629 | 4 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Oral | 0 | 2 | MG | QD | ||||||||
| 124966292 | 12496629 | 5 | SS | FLUOROURACIL. | FLUOROURACIL | 1 | 0 | Q3W | |||||||||||
| 124966292 | 12496629 | 6 | SS | LEVOMEPROMAZINE | LEVOMEPROMAZINE | 1 | 0 | ||||||||||||
| 124966292 | 12496629 | 7 | SS | METOCLOPRAMIDE. | METOCLOPRAMIDE | 1 | 0 | ||||||||||||
| 124966292 | 12496629 | 8 | SS | NEULASTA | PEGFILGRASTIM | 1 | Subcutaneous | 0 | 6 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124966292 | 12496629 | 1 | Product used for unknown indication |
| 124966292 | 12496629 | 2 | Product used for unknown indication |
| 124966292 | 12496629 | 3 | Product used for unknown indication |
| 124966292 | 12496629 | 4 | Product used for unknown indication |
| 124966292 | 12496629 | 5 | Product used for unknown indication |
| 124966292 | 12496629 | 6 | Product used for unknown indication |
| 124966292 | 12496629 | 7 | Product used for unknown indication |
| 124966292 | 12496629 | 8 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124966292 | 12496629 | HO |
| 124966292 | 12496629 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124966292 | 12496629 | Arthralgia | |
| 124966292 | 12496629 | Constipation | |
| 124966292 | 12496629 | Decreased appetite | |
| 124966292 | 12496629 | Deep vein thrombosis | |
| 124966292 | 12496629 | Fatigue | |
| 124966292 | 12496629 | Oral pain | |
| 124966292 | 12496629 | Pain | |
| 124966292 | 12496629 | Pain in extremity | |
| 124966292 | 12496629 | Peripheral swelling | |
| 124966292 | 12496629 | Vascular pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |